BIOCRYST PHARMACEUTICALS, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.03 | $-116.24 |
| FY2022 | $-1.33 | $-116.28 |
| FY2023 | $-1.18 | $-116.33 |
| FY2024 | $-0.43 | $-116.28 |
| FY2025 | $1.21 | $-116.08 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.03 | $-116.24 |
| FY2022 | $-1.33 | $-116.28 |
| FY2023 | $-1.18 | $-116.33 |
| FY2024 | $-0.43 | $-116.28 |
| FY2025 | $1.21 | $-116.08 |